Back to Journals » OncoTargets and Therapy » Volume 7

Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity

Total article views   HTML views PDF downloads Totals
7,841 Dovepress* 6,994+ 1,301 8,295
PubMed Central* 847 299 1,146
Totals 7,841 1,600 9,441
*Since 21 March 2014
+Since July 2016

View citations on PubMed Central and Google Scholar